리커너스_베이직

• Transition from Sole Leadership by Professor Jaesoon Choi of Asan Medical Center to a Co-CEO System, Enhancing Expertise in R&D and Management

• CEO Donghee Kim: “Leveraging Healthcare Expertise and Leadership to Drive LN Robotics’ Global Expansion”

AI and medical robotics specialist LN Robotics (CEOs Jaesoon Choi, Donghee Kim) announced on the 4th that it has appointed Donghee Kim as its new CEO.

LN Robotics specializes in developing medical robots, including cardiovascular intervention robots. The company received approval from the Ministry of Food and Drug Safety (MFDS) in February 2023 for its AVIAR system, which assists in coronary angiography and intervention, and obtained New Excellent Technology (NET) certification from the Ministry of Health and Welfare in December of the same year. Recently, its "Percutaneous Coronary Intervention Using the AVIAR Catheter Control Robot" was designated as an innovative medical technology.

The newly appointed CEO, Donghee Kim, has accumulated over 20 years of expertise and leadership in the healthcare industry through various roles at global healthcare companies. Before joining LN Robotics, she served as the CEO of Philips Korea (2018–2021) and led the Health Systems business for Philips Asia-Pacific (2021–2022), driving business growth across key Asian markets.

Kim is particularly recognized for her extensive experience and deep understanding of the cardiovascular treatment sector and related markets. From 2011 to 2018, she led the transcatheter aortic valve implantation (TAVI) business in major Asia-Pacific markets at Edwards Lifesciences. Prior to that, from 2004 to 2011, she led marketing for key products such as drug-eluting stents and intracardiac ultrasound at Boston Scientific’s cardiovascular division.

Commenting on her appointment, CEO Donghee Kim stated, “The field of cardiovascular treatment and medical robotics presents high technological barriers and market entry challenges, making global expansion difficult for domestic companies.” She added, “Leveraging my 20 years of experience in multinational medical technology firms and my professional network, I will strive to promote LN Robotics’ cutting-edge medical robotics technology in global markets and ensure its successful adoption.”

She further emphasized, “Ultimately, through open innovation and various partnerships, I aim to improve the clinical environment for healthcare professionals and contribute to the health and well-being of cardiovascular patients worldwide.”

Meanwhile, Donghee Kim initially joined LN Robotics as an advisory board member in January 2024. In October of the same year, during the company’s restructuring to separate the R&D and business operations divisions, she took on the role of overseeing the business sector. Previously, Professor Jaesoon Choi of the Asan Medical Center’s Biomedical Engineering Research Institute had served as the sole CEO. With the new co-CEO structure, each leader will leverage their expertise to ensure responsible management in R&D and business operations.